Early Termination of Drug Trials: What Are the Ramifications for Drug Companies and Drug Safety Monitoring Boards?
Jensen, Gorm Boje
BMJ: British Medical Journal 2007 February 17; 334(7589): 326
Showing items related by title, author, creator and subject.
Toward a More Comprehensive Approach to Protecting Human Subjects: The Interface of Data Safety Monitoring Boards and Institutional Review Boards in Randomized Clinical Trials Gordon, Valery M.; Sugarman, Jeremy; Kass, Nancy (1998-01)
Data Safety Monitoring Boards and Other Study Methodologies That Address Subject Safety in "High-Risk" Therapeutic Trials in Youths Carandang, Carlo; Santor, Darcy; Gardner, David M.; Carrey, Normand; Kutcher, Stan (2007-04)
Simberkoff, Michael S.; Hartigan, Pamela M.; Hamilton, John D. (VA Cooperative Study Group on AIDS Treatment (New York, NY), 1993-02)